00828nam a2200181 a 450000500170000000800410001702000180005803500150007605000260009124502450011726000470036230000410040965000210045065000430047165000230051471000300053785600790056720260817161355.0251029s2025    sz a    o     000 0 eng d  a9789240116092  a.b12466396 4aRC271 A35bA23 2025eb00aAccelerating the development of priority formulations in childhood cancerh[electronic resource] :btarget product profiles for paediatric formulations of cyclophosphamide, etoposide, mercaptopurine, methotrexate, procarbazine, temozolomide  aGeneva :bWorld Health Organization,c2025  a1 online resource (63 pages) :bill. 0aDrug development 0aCancer in childrenxAdjuvant treatment 0aCancer in children2 aWorld Health Organization  3Free eBook from WHOuhttps://www.who.int/publications/i/item/9789240116092